Trials / Sponsors / Darnitsa Pharmaceutical Company
Darnitsa Pharmaceutical Company
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Bioequivalence Study of Test and Reference 400 mg Ibuprofen Coated Tablets in Healthy Volunteers Bioequivalence, Healthy Subjects | Phase 1 | 2022-05-17 |
| Completed | Bioequivalence Study of Test and Reference 50 mg Eplerenone Film-coated Tablets in Healthy Volunteers Bioequivalence, Healthy Subjects | Phase 1 | 2021-12-07 |
| Completed | Efficacy and Safety Study of Ketorolac / Pitofenone / Fenpiverinium for the Treatment of Patients With Pain Af Postsurgical Pain | Phase 2 / Phase 3 | 2021-07-07 |
| Completed | Bioequivalence Study of 8 mg Perindopril Tert-Butylamine / 2.5 mg Indapamide / 10 mg Amlodipine Tablets Versus Bioequivalence, Healthy Subjects | Phase 1 | 2021-05-30 |
| Completed | Bioequivalence Study of 8 mg Perindopril Tert-butylamine / 2.5 mg Indapamide Tablets Versus 10 mg Perindopril Bioequivalence, Healthy Subjects | Phase 1 | 2021-05-19 |
| Completed | Bioequivalence Study of Test and Reference 120 mg Etoricoxib Film-coated Tablets in Healthy Volunteers Bioequivalence, Healthy Subjects | Phase 1 | 2021-02-24 |